AzTrials
AzTrials

Free Gingival GraftNCT07651423

Evaluating the Effect of Blue m Gel on Healing of Palatal Donor Site Versus Using Diode Laser

A study testing Blueb m gel and Laser therapy in people with Free Gingival Graft and Laser, run by Delta University for Science and Technology at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A sample size of 40 patients, Group A of 20 patients treated with blue m gel and Group B of 20 patient treated with diode laser were included in this study after free gingival grafts harvested from the hard palate. Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Free Gingival Graft, Laser
What is being tested?
Blueb m gel and Laser therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
1 siteEgypt
Study dates
1 Jun 2025to 1 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • healthy

Who cannot join

  • smokers

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Delta University For Science and Technology

    Gamasa, Dakhalia, 35516

Other trials in Egypt

About this study

A sample size of 40 patients, Group A of 20 patients treated with blue m gel and Group B of 20 patient treated with diode laser were included in this study after free gingival grafts harvested from the hard palate. Participants were assessed for the amount and duration of bleeding, pain duration, and the risk of infection 2, 7,14, 30 days post-operative

Being tested
Blueb m gel, Laser therapy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blueb m gelProcedure or surgery

    application of blue m oxygen releasing oral gel to the palate after free gingival graft

  • Laser therapyProcedure or surgery

    Application of Low level laser therapy to the Paltal donor site after free gingival graft harvesting

Study groups in NCT07651423
Study groupRoleWhat they receive
blue m gel groupExperimentalapplication of blue m gel
Receives: Procedure: Blueb m gel
laser groupExperimentalapplication of laser
Receives: Procedure: Laser therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain intensity

    visual analogue scale

    Measured: one month

Secondary outcomes (1)
  1. Bleeding time

    Presence or absence of bleeding

    Measured: One week

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Jun 2026
  2. Study start1 Jun 2025
  3. Primary completion31 Dec 2025
  4. Study completion1 Feb 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07651423
Sponsor's protocol ID
DU025052214
Status last verified
Jun 2026
First submitted
9 Jun 2026
Last updated
20 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Blueb m gel and Laser therapy in people with Free Gingival Graft and Laser, run by Delta University for Science and Technology at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain intensity (time frame: one month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in